BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 5161339)

  • 1. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG; Corrodi H; Masuoka DT
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between catecholamines and serotonin in sympathetic nerves of the rat pineal gland.
    Zweig M; Axelrod J
    J Neurobiol; 1969; 1(1):87-97. PubMed ID: 4400911
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of social stress on the turnover of brain catecholamines and 5-hydroxytryptamine in mice.
    Modigh K
    Acta Pharmacol Toxicol (Copenh); 1974 Feb; 34(2):97-105. PubMed ID: 4545032
    [No Abstract]   [Full Text] [Related]  

  • 4. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD; Cattabeni F; Costa E
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain amine levels and competitive behavior between rats in a straight runway.
    Masur J; Czeresnia S; Skitnevsky H; Carlini EA
    Pharmacol Biochem Behav; 1974; 2(1):55-62. PubMed ID: 4275179
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of (+-)-p-chloroamphetamine on the susceptiblity to seizures and on the monoamine level in brain and heart of mice and rats.
    Pfeifer AK; Galambos E
    J Pharm Pharmacol; 1967 Jun; 19(6):400-2. PubMed ID: 4382372
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of neurogenic amines to aggregation and strangers.
    Bliss EL; Ailion J
    J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of brain catecholamines with cortical acetylcholine outflow, behaviour and electrocorticogram.
    Beani L; Bianchi C; Castellucci A
    Eur J Pharmacol; 1974 Apr; 26(1):63-72. PubMed ID: 4831985
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of brain dopamine to stress-induced changes in seizure susceptibility.
    Goldberg ME; Salama AI
    Eur J Pharmacol; 1970; 10(3):333-8. PubMed ID: 5422459
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S
    Pharmacol Biochem Behav; 1973; 1(3):347-50. PubMed ID: 4775861
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropeptide Y alters monoamine turnover in the rat brain.
    Vallejo M; Carter DA; Biswas S; Lightman SL
    Neurosci Lett; 1987 Jan; 73(2):155-60. PubMed ID: 3822247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of psychotomimetic glycolate esters on central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    Eur J Pharmacol; 1972 Jan; 17(1):97-102. PubMed ID: 4401437
    [No Abstract]   [Full Text] [Related]  

  • 17. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 18. A reliable method for the simultaneous estimation of dopamine, noradrenaline and serotonin in discrete areas of brain.
    Butterworth RF; Landreville F; Guitard M; Barbeau A
    Clin Biochem; 1975 Oct; 8(5):298-302. PubMed ID: 1201621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.
    Bloom FE; Algeri S; Groppetti A; Revuelta A; Costa E
    Science; 1969 Dec; 166(3910):1284-6. PubMed ID: 5350323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation by restraint stress of a mechanism to conserve brain catecholamines and serotonin in mice differing in excitability.
    Welch BL; Welch AS
    Nature; 1968 May; 218(5141):575-7. PubMed ID: 5655184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.